Robitussin and Lanoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Robitussin (guaifenesin) and Lanoxin (digoxin). Common drug interactions include arteriosclerosis among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Robitussin and Lanoxin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Robitussin?

Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.



On Aug, 08, 2026

19 people who take Robitussin and Lanoxin together, and have interactions are studied.

Robitussin and Lanoxin drug interactions.

What are the common drug interactions of Robitussin and Lanoxin, by gender? *:

female:

  1. Arteriosclerosis (thickening and hardening of arteries)
  2. Blood urea increased
  3. Cardiac arrest
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Debility (physical weakness)
  6. Diarrhoea
  7. Digoxin toxicity
  8. Drug maladministration
  9. Flushing (the warm, red condition of human skin)
  10. Fungal infection

male:

  1. Cough
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Dyspnoea (difficult or laboured respiration)
  4. Electrocardiogram st segment elevation
  5. Extrasystoles
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  8. Hypercapnia (too much smoke)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

What are the common drug interactions of Robitussin and Lanoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Fungal infection
  3. Headache (pain in head)
  4. Lung disorder (lung disease)
  5. Neck pain
  6. Pain in jaw

50-59:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Tachypnoea (a condition of rapid breathing over 20 per minute)
  3. Thrombocytosis
  4. Viral infection
  5. Vomiting
  6. Weight increased
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. White blood cell count increased
  9. Hospitalisation
  10. Oropharyngeal pain

60+:

  1. Hypotension (abnormally low blood pressure)
  2. Pyrexia (fever)
  3. Oral candidiasis (fungal infection of mouth)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Platelet count decreased
  6. Rales (an abnormal respiratory sound characterized by fine crackles)
  7. Rhonchi (abnormal breath sounds)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  10. Arteriosclerosis (thickening and hardening of arteries)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 15.79%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.26%
  3. Pain: 1 person, 5.26%
  4. Emotional Distress: 1 person, 5.26%
  5. Birth Control: 1 person, 5.26%
  6. Autonomic Failure Syndrome (a degenerative disease of the autonomic nervous system): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Robitussin and Lanoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Robitussin and Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Robitussin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Robitussin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lanoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on guaifenesin and digoxin (the active ingredients of Robitussin and Lanoxin, respectively), and Robitussin and Lanoxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: